A US drug maker pays health plans, and the pharmacy benefit managers that run their drug lists, to cover its medicines. Those payments rest on many signed contracts that get amended over time. Each contract sets rates, fees and a long list of dates. Payer contract management keeps those terms readable, gets each date to the person who owes it, and checks every payment against the words that were signed.
This guide is for anyone who negotiates, reads, pays or signs these contracts: market access and managed markets teams, contract operations, gross-to-net and revenue accounting, government pricing, contracts counsel, and the leaders deciding whether to automate the work. No background needed.
Imagine you are the contract operations lead at Northwind Bio, a mid-sized US drug maker with three brands and 20 payer agreements worth $4.24 billion gross a year. It is Wednesday, October 7, 2026, and you open your month: 42 dated duties, 31 still open.
Two of them should worry you. Summitview Rx, a pharmacy benefit manager with a $220 million agreement, can be ended only by written notice 90 days before its term ends on January 10, 2027. The last day is Monday, October 12, five days away. If nothing goes out, the agreement renews for a year, with a fee above your company's limit.
And last Thursday you paid Crestline Rx an administrative fee, set as a percent of the drug's list price (its WAC). Side by side, the invoice and the contract disagree.
Signed agreement · §6.1
Fee
4.0% of WAC
Eligible Q2 sales
$310.0M
Amount owed
$12.40M
Payer's fee invoice · Q2
Fee
4.5% of WAC
Billed from
Its standard schedule
Amount paid
$13.95M
$1.55M paid above the clause90 days to dispute itthe window runs from the invoice.
Careful contract work catches the notice before the deadline and the half-point overcharge before the dispute window closes. Worked from PDFs and spreadsheets, both can pass unnoticed.
Payer contracting for drug makers: the deals, the clauses, Best Price, service fees and the 2026 law
Who signs these contracts, what they make you do and when, how one rate can move Medicaid rebates, what the law now says about fees, what goes wrong and how teams run the work today. No product here. If you are new to market access, the work of getting a drug covered and paid for, start with section 1.
01 · In plain words
What payer contract management means at a US drug maker, told as one contract's life
In the United States, most people get a prescription medicine through a health plan. The plan keeps a list of the drugs it covers, called a formulary, and usually hires a pharmacy benefit manager (PBM) to run that list. A drug in a favored spot on the list gets prescribed and filled more often. So a drug maker pays for the spot. It agrees to pay back part of the list price for each pack dispensed, and that payment is a rebate.
The promise goes into a contract. A mid-sized drug maker can hold dozens of them, with PBMs, commercial health plans, Medicare drug plans, hospital systems, buying groups, specialty pharmacies, employer coalitions and state Medicaid pools. In our running example, a fictional company called Northwind Bio has 20. Every year the parties sign amendments that change a rate here and a date there, until the deal in force is spread across four or five documents.
Those documents create work with dates on it. Tell the other side 90 days before the term ends if you want out. Send a claims file 45 days after each quarter. Pay within 60 days of a complete invoice. Check the list price each quarter for a rebate that rises when the price does. Dispute a wrong invoice within 90 days. Northwind's 20 contracts make 42 such duties in October alone.
Payer contract management is the job of keeping all of that straight: reading each signed document into terms someone can use, a step teams call contract abstraction, knowing which terms are in force on any date, putting each duty in front of its owner in time, and checking what was paid against what was signed. It sits in the gap between the people who negotiate a deal and the systems that pay it, and much of it still runs on PDFs and spreadsheets.
From a negotiated rate to a renewal: five steps in one payer deal
Negotiators on the deal desk strike a dealNorthwind offers a health plan 38.0% off list price for its brand Dravenzo, in return for being the only preferred brand in its class.
Lawyers sign an agreement or amendmentNorthgate Health Plan signs Amendment No. 2 on October 6, 2026. Ten values change from January 1, 2027.
Someone reads it into terms and datesRates, fees, exclusions, clocks and owners, each traced to its clause. This is where a Medicaid pricing problem gets seen, or missed.
Finance pays against it, quarter after quarterRebate invoices, fee invoices, chargebacks (credits to wholesalers for contract prices) and accruals (finance's estimates of what is owed) all run on the terms someone keyed.
The term ends, or quietly renewsSilence past the notice date buys another year on the same terms.
Step 3 is the subject of this guide, and it decides whether steps 4 and 5 go right. The people, companies and figures in this example are fictional.
A plan's rate that moves Medicaid, and three more surprises in rebate contracts
One plan's rate can raise what you owe every state
Medicaid's rebate depends on the lowest price the maker gave almost anyone that quarter. A deep discount to one health plan can set that price.1,2 Rebates to PBMs mostly sit outside the rule, so the same rate means different things in two contracts.
Doing nothing is a decision
An evergreen clause renews the contract unless someone gives notice in time. One legal guide calls forgetting the date a common pitfall, "leading to unplanned obligations".3
The other side writes the bill
Payers invoice the maker. Trade reporting describes commercial rebate requests that do not match the contract, checked by under-resourced teams on spreadsheets and SQL.4
A common fee form has an end date
Many administrative fees are a percent of list price. For fees to PBMs on Medicare's drug benefit, Part D, a law signed on February 3, 2026 requires a flat dollar amount for plan years from January 1, 2028.5,6
WAC, Best Price, bona fide service fee, terms in force
WAC
Wholesale acquisition cost: the drug's list price to wholesalers. Rebates and fees are usually written as a percent of it.
Best Price
The lowest price a maker gave to nearly any US buyer in a quarter, after rebates and discounts. It feeds the Medicaid rebate.
Bona fide service fee
A fee at fair market value for a real, itemized service. It stays out of Best Price. A fee that fails the test can count as a discount.
Terms in force
What the deal says on a given date, after applying every amendment in order to the base agreement.
Who signs a payer agreement with a manufacturer, and what each side gets from it
In shortA drug maker buys access: a favored spot on a list of covered drugs. It pays with rebates after the drug is dispensed, plus fees for services. Three PBMs handle four of every five prescriptions, so a few contracts carry most of the money, and eight kinds of counterparty each bring their own clauses.
The rebate money moves months after the sale, in a loop that runs alongside it. The pharmacy fills the prescription, the plan pays the pharmacy, the plan or PBM reports what was dispensed, and the maker pays the rebate on that report.
A rebate is paid months after the sale, on a report the payer writes
1Sale at list price
The maker sells to a wholesaler at about WAC. A pharmacy buys from the wholesaler.
Maker, wholesaler
2Prescription filled
The plan pays the pharmacy for the prescription and the member pays a share.
Pharmacy, plan
3Report and invoice
After the quarter, the plan or PBM reports units dispensed and invoices the rebate and fees.
Plan or PBM
4Validate and pay
The maker checks the invoice against the contract and pays, inside the contract's clock.
Revenue accounting
5True-up
Accruals are corrected, disputes are settled, and pricing reports take in the final numbers.
The maker sells to a wholesaler at about WAC. A pharmacy buys from the wholesaler.
Maker, wholesaler
Prescription filled
The plan pays the pharmacy for the prescription and the member pays a share.
Pharmacy, plan
Report and invoice
After the quarter, the plan or PBM reports units dispensed and invoices the rebate and fees.
Plan or PBM
Validate and pay
The maker checks the invoice against the contract and pays, inside the contract's clock.
Revenue accounting
True-up
Accruals are corrected, disputes are settled, and pricing reports take in the final numbers.
Finance, government pricing
The US Government Accountability Office (GAO) read 2020 Part D rebate agreements between six drug makers and six plan sponsors, the companies that run Part D plans. It found the same bargains in all of them: a rebate for the lowest cost-sharing tier (the group of drugs on which members pay least), a higher rebate when fewer competitors share the tier, and rebates that depend on competitors facing restrictions. At least half also bundled rebates across a maker's drugs.7
Each condition has to be checked before the rate applies, and one vendor names a wrong formulary position as a way makers overpay.9
Three PBMs process about 80% of US prescription claims
Equivalent prescription claims in 2025, billions
Express Scripts2.22
CVS Caremark1.9
Optum Rx1.66
Prime Therapeuticsabout half is counted inside Express Scripts0.407
Source10 · Caremark's volume is given as about 1.9 billion.
Show the numbers
PBM
Claims, billions
Express Scripts
2.22
CVS Caremark
1.9
Optum Rx
1.66
Prime Therapeutics
0.407
Each of the three is tied to a rebate group purchasing organization (Ascent, Zinc and Emisar) that negotiates with makers, mostly for commercial business.10 So the signature on a rebate contract may belong to an entity the brand team has never dealt with.
Eight kinds of payer contract, and what is different about each
Counterparty
What the contract usually buys
What to watch
National PBM
Formulary position across many clients
Administrative fee rate, fee schedule versus clause, 340B exclusion
Eligibility, 340B exclusions, short notice periods
State Medicaid pool or Medicaid plan
A preferred listing, for a supplemental rebate
Supplemental rebates to state agencies, authorized by the Centers for Medicare & Medicaid Services (CMS), are excluded from Best Price;1 other Medicaid deals need review
340B is the federal program of discounted prices for safety-net providers; section 5 shows how it connects to Medicaid. A safe harbor is a set of conditions that protects a payment arrangement under the federal anti-kickback law.
03 · Clauses and their dates
The seven kinds of dated duty inside a rebate agreement and how to read them
In shortMost of what a payer contract asks of you has a date on it. Data files and payments make up most of the volume, and notice deadlines are the rarest. A single missed notice can cost more than a year of late files. Obligation tracking starts by finding each clock, its starting event and who owes it.
Data files and payments are most of a month; the one notice deadline matters most
Northwind Bio's 42 duties in October 2026, by kind
42duties
Data files17
Payments11
Fee reviews6
Notice, renewal and audit5
Price protection3
Fictional example from this guide · Notice 1, term and renewal 2, audit 2.
Show the numbers
Part
Value
Data files
17
Payments
11
Fee reviews
6
Notice, renewal and audit
5
Price protection
3
Duty
What the clause says, in plain words
Example from Northwind's contracts
Who usually owes it
Notice
The last day to say you will end or not renew
Summitview: 90 days before January 10, 2027
Deal desk
Term and renewal
When the term ends, and what happens next
Copperline Purchasing Alliance ends November 30, 2026, and needs a new fair-market-value study
Deal desk, legal
Price protection
If list price rises above a threshold, the rebate rises by the excess
Northgate: 7.0% a year on net WAC, moving to 5.0% on actual WAC
Revenue accounting
Audit
Who may audit whom, how far back, on how much notice
Northgate's look-back on Northwind's payments grows from 24 to 36 months
Contract operations
Data
Files owed on a clock, often from the payer
Claim-level utilization (what was dispensed) 45 days after quarter end
Contract operations
Payment
Days to pay from a complete invoice
60 days is the standard; a PBM's 45 days falls below it
Revenue accounting
Fee review
Reports, true-ups and fair-market-value checks on a fee
A signed statement that a buying group's fee still reflects fair market value
Legal, finance
How "net WAC" and "actual WAC" change a price protection rebate
A price protection clause guards the payer against list price rises. Suppose WAC goes up 8% in a contract year and the clause protects above 7.0%: the maker owes an extra rebate on the excess. The baseline date matters too: move it and every future comparison shifts.
Two words change the result. "Net WAC" measures from a figure already reduced by rebates, and "actual WAC" measures the list price itself. Northgate's amendment moves from the first to the second and drops the threshold to 5.0%, so a price rise that was free last year now costs money: a planned 5.9% January change would trigger 0.9% of WAC on Northgate's units, about $0.34 million a year.
Reading for dates means reading for clocks. Each dated duty has four parts: the event that starts the clock, the number of days, whether they count as calendar or business days, and the person who owes it. If any of the four lives in a schedule or an earlier amendment, a reader working from one PDF will miss it.
04 · The rules and their dates
The federal rules behind payer contracts, and what changed between 2024 and 2026
In shortNo single law governs a payer contract. Medicaid rules decide when a price or fee counts, Medicare and antitrust actions now reach how fees are set, and 340B rules decide which units carry a rebate at all. The biggest change is the Consolidated Appropriations Act, 2026, which takes percent-of-list PBM fees out of Part D for plan years from January 1, 2028.
Fee and rebate rules are being rewritten on dates that fall inside today's contracts
Jan 1, 2024Medicaid rebate cap ends
The limit of 100% of the average manufacturer price (AMP) covers rebate periods before this date.
Nov 19, 2024Medicaid rebate rule changes take effect
CMS-2434-F, published September 26, 2024. Its proposal on adding discounts together, called stacking, was left out.
Jan 1, 2026First Medicare negotiated prices
Ten drugs. Fifteen more follow on January 1, 2027.
Feb 3, 2026Consolidated Appropriations Act, 2026 signed
Part D and employer plan reforms for PBMs.
Feb 4 and Jul 14, 2026Federal Trade Commission (FTC) settles with Express Scripts, then Caremark
Proposed orders: in each standard offering, fees from manufacturers may not rest on list price.
Oct 20, 2026CMS proposes its Part D PBM rule
CMS-4214-P. Comments close December 15, 2026.
Jan 1, 2027Revised 340B rebate pilot due to start
Selected drugs only. A new court challenge was filed on October 9, 2026.
Jan 1, 2028Part D flat fee rule
For plan years from this date: bona fide service fees only, a flat dollar amount.
Jan 1, 2029Employer plan pass-through
Rebates passed in full to employer plans under ERISA, the federal benefits law. For calendar-year plans; plan years beginning 30 months after enactment.
Federal Trade Commission (FTC) settles with Express Scripts, then Caremark
Oct 20, 2026
CMS proposes its Part D PBM rule
Jan 1, 2027
Revised 340B rebate pilot due to start
Jan 1, 2028
Part D flat fee rule
Jan 1, 2029
Employer plan pass-through
Rule
What it does to a contract
Status, November 2026
Medicaid rebate statute, 42 U.S.C. 1396r-8
Sets the rebate as the greater of 23.1% of AMP or AMP less Best Price. Best Price includes the maximum fair price, Medicare's negotiated price, for a selected drug.2
In force
Best Price rule, 42 CFR 447.505
Says which prices count, and that Best Price is net of administrative and service fees except bona fide ones.1
In force; parts of (c) revised effective November 19, 2024
Quarterly reports within 30 days, revisions up to 12 quarters, executive certification, records for 10 years.20
In force
340B statute, 42 U.S.C. 256b
Sets the ceiling price, the most a 340B provider pays, from AMP and the rebate, and bars duplicate discounts.21
In force; rebate pilot contested
Buying group (GPO) safe harbor, 42 CFR 1001.952(j)
Asks for a written agreement, a fee of 3% or less or a stated amount, and yearly disclosure to providers.12
In force
Consolidated Appropriations Act, 2026
Part D: flat, fair-market-value service fees for PBMs, and rebates passed in full to the plan sponsor (pass-through). Within 30 days, PBMs explain to sponsors any manufacturer contract that ties rebates to coverage of other drugs, and the Department of Health and Human Services (HHS), consulting its inspector general (OIG), reviews fee arrangements. Employer plans: 100% pass-through.5,11
Enacted. CMS proposed its Part D rule on October 20, 2026, with comments due December 15; not final6
Proposed FTC orders on PBMs
In each PBM's standard offering to plan sponsors, fees from manufacturers cannot rest on list price, under proposed orders with Express Scripts and Caremark.16,17,22,23
Both put out for public comment. The FTC's PBM page, read November 3, 2026, lists no final order. The FTC took OptumRx's case out of its hearing process in June 2026 to consider a consent agreement17,23
GENEROUS Medicaid model
Voluntary, January 1, 2026 to December 31, 2030. Its supplemental rebates do not affect Best Price or 340B ceilings.24
Launched January 2026, per CMS; state applications ran to September 30, 202625
Plain summaries, for orientation. The Act's text and any final HHS rule on fair market value decide the details: ask counsel before relying on any line here.
05 · Best Price, worked through
How one health plan amendment sets a new Medicaid Best Price: the calculation, step by step
In shortMedicaid's basic rebate is the larger of 23.1% of the average manufacturer price (AMP), the average a maker receives on sales to retail pharmacies, or AMP less Best Price. So when a contract sets a price below today's Best Price, the rebate on every Medicaid unit rises by the difference. In the running example, a rate 8 points higher to one plan adds about $3.55 million of Medicaid rebate a quarter.
Best Price is "the lowest price available from the manufacturer during the rebate period to any wholesaler, retailer, provider, health maintenance organization, nonprofit entity, or governmental entity".1 The rule's word "provider" expressly includes a health maintenance organization (HMO) and a managed care organization, and it counts discounts and rebates that adjust a price directly or indirectly. That is why a commercial health plan's rebate counts.
Dravenzo at 38.0%: from a list price to a Medicaid bill
Step
Arithmetic
Result
List price per bottle
WAC
$612.00
Rebate at the new exclusive rate
38.0% × $612.00
$232.56
Lowest net price under this contract
$612.00 − $232.56
$379.44
Today's Best Price, from a hospital system
Pricing record, Q2 2026
$409.42
Minimum rebate test
23.1% × AMP of $561.20
$129.64
Unit rebate today
$561.20 − $409.42, larger than $129.64
$151.78
Unit rebate after
$561.20 − $379.44
$181.76
Cost on Medicaid units
$29.98 × 118,400 units a quarter
About $3.55M a quarter
Fictional example. These figures are the basic rebate only, before any inflation-based rebate, and they hold AMP and the units steady, which a real calculation would not.
The exclusive rate lands below today's Best Price, and a failed fee pushes it lower still
Dravenzo, per bottle
List price (WAC)$612
Today's Best Price$409.42
Lowest net at 38.0%$379.44
Lowest net if the 5.5% fee counts as a discount$345.78
Fictional example from this guide
Show the numbers
Price
Per bottle
List price (WAC)
$612
Today's Best Price
$409.42
Lowest net at 38.0%
$379.44
Lowest net if the 5.5% fee counts as a discount
$345.78
The same $29.98 lands twice: Medicaid and the 340B ceiling price
The 340B program lets safety-net providers buy at a ceiling price, set by statute as AMP reduced by the rebate percentage.21 A larger Medicaid rebate therefore lowers the 340B ceiling. On the example's figures, that takes the ceiling from about $409.42 to about $379.44. So a price review that counts only Medicaid units understates the cost: 340B volume falls in price by the same amount. The Medicaid rebate's old cap of 100% of AMP gives no relief: it stopped at rebate periods beginning January 1, 2024.2
A lower Best Price raises the Medicaid rebate and lowers the 340B ceiling by the same amount
Dravenzo, per bottle, on the example's AMP of $561.20
TodayAfter the amendment
Medicaid unit rebate$151.78$181.76
340B ceiling price (AMP less rebate)$409.42$379.44
Fictional example from this guide · Simplified: basic rebate only, our arithmetic on the fictional figures.
Show the numbers
Today
After the amendment
Medicaid unit rebate
$151.78
$181.76
340B ceiling price (AMP less rebate)
$409.42
$379.44
Whose price counts toward Best Price, by kind of contract
A plan's rebate counts; a PBM's rebate usually does not, unless it adjusts a price at retail or provider level
ExcludedDepends on the factsCounts
Toward Best PriceCommercial health plan or HMO rebateCountsHospital or health system priceCountsPBM rebate, retailDepends on the factsPBM mail order pharmacy's purchasesCountsPart D or Medicare Advantage drug plan negotiated priceExcludedSupplemental rebate to a state agency, CMS-authorizedExcludedGENEROUS model supplemental rebateExcluded340B provider priceExcludedDirect sale to a patientExcludedBona fide service feeExcluded
Our reading of the sources1,24 · PBM rebates are excluded except mail order purchases and transactions designed to adjust prices at the retail or provider level. Your government pricing team decides each case.
Show the numbers
Toward Best Price
Commercial health plan or HMO rebate
Counts
Hospital or health system price
Counts
PBM rebate, retail
Depends on the facts
PBM mail order pharmacy's purchases
Counts
Part D or Medicare Advantage drug plan negotiated price
Excluded
Supplemental rebate to a state agency, CMS-authorized
Excluded
GENEROUS model supplemental rebate
Excluded
340B provider price
Excluded
Direct sale to a patient
Excluded
Bona fide service fee
Excluded
Two points that are still moving. Stacking asks whether two discounts given to different entities on one unit must be added together for Best Price. CMS proposed a rule and chose in September 2024 to leave it out and gather more data, noting a federal survey in which about half of responding makers said they stacked.14 And for a drug in Medicare negotiation, Best Price is "inclusive of the maximum fair price",2 so a selected drug's contracts need a fresh look even if no rate in them changed.
Why a Best Price review after countersignature comes too late
The rate takes effect only at the amendment's start date, but the signature is what binds the maker. Once the maker countersigns, adding its signature to the payer's, the choices narrow to a renegotiation. Reports then run on their own clock: a quarterly report within 30 days of the quarter's end, a certified signature on it, revisions possible for 12 quarters, and records for 10 years "including a record of any assumptions made".20 The maker must also adjust Best Price later if cumulative discounts or rebates change the price available.1
06 · Service fees and the 2026 law
The bona fide service fee test, and why percent-of-WAC administrative fees are on a deadline
In shortA fee stays out of Best Price only if it passes four tests: an itemized service actually performed, at fair market value, one the maker would otherwise do or buy, and kept by the entity. If it fails, it can count as a price cut. For plan years from January 1, 2028, the fees PBMs earn on Part D must also be a flat dollar amount that does not rest on a drug's price.
Four tests in one sentence of federal rule
The rule defines a bona fide service fee as "a fee paid by a manufacturer to an entity that represents fair market value for a bona fide, itemized service actually performed on behalf of the manufacturer that the manufacturer would otherwise perform (or contract for) in the absence of the service arrangement, and that is not passed on in whole or in part to a client or customer".13
Test 1 · the service
Itemized and actually performed
The contract and its exhibit name each service. Someone can show it was done. Deleting that exhibit, as Northgate's amendment does, removes the list.
Test 2 · the price
Fair market value
The fee matches what the service would cost at arm's length, usually backed by a study. A fee rising from 3.0% to 5.5% with no new service invites the question.
Tests 3 and 4 · the need and the money
Would otherwise buy it, and keeps it
The maker would do the work or pay someone else to. And the entity does not pass the fee on to its clients, which is hard to know without asking and auditing.
One failed fee, three outcomes: health plan, PBM and buying group
The penalty for failure runs through the price. Best Price "is net of" administrative fees and service fees "except bona fide service fees".1 So the same words need a different review in each kind of contract.
Fee to a health plan
A failed fee lowers the net price
In the example, a failing 5.5% fee takes the lowest net from $379.44 to $345.78.
Fee to a PBM
A failed fee may fall outside Best Price
The rule excludes PBM "rebates, discounts, or other financial transactions" from Best Price, except a PBM mail order pharmacy's purchases and transactions designed to adjust prices at the retail or provider level.1 We read that to mean a failed fee to a PBM may fall outside Best Price. We found no CMS statement of it, and your government pricing team and counsel decide.
Fee to a buying group
A test of its own
A buying group's fee also answers to the 3% safe harbor.12
Where an exhibit is deleted, two of the four tests have nothing behind them
Four fees from Northwind's contracts, as the contract file shows them
MissingNot shownOn file
Itemized serviceFair market value supportWould otherwise buyNot passed onCrestline Rx, 4.0%, Exhibit COn fileOn fileNot shownNot shownSummitview Rx, 4.5%, above the company's limitNot shownNot shownNot shownNot shownNorthgate, 5.5%, exhibit deletedMissingMissingNot shownNot shownCopperline, 3.0%, study dueOn fileNot shownNot shownNot shown
Fictional example from this guide
Show the numbers
Itemized service
Fair market value support
Would otherwise buy
Not passed on
Crestline Rx, 4.0%, Exhibit C
On file
On file
Not shown
Not shown
Summitview Rx, 4.5%, above the company's limit
Not shown
Not shown
Not shown
Not shown
Northgate, 5.5%, exhibit deleted
Missing
Missing
Not shown
Not shown
Copperline, 3.0%, study due
On file
Not shown
Not shown
Not shown
What the Consolidated Appropriations Act, 2026 changes for fee clauses
These provisions apply for Part D plan years from January 1, 2028. CMS published its proposed rule on October 20, 2026, and comments close December 15, 2026.6
Provision
What the Act says
PBM pay
PBM and affiliate pay tied to drug use is limited to bona fide service fees.5
Fee form
Each fee must be a "flat dollar amount" and must not be based on a drug's price such as WAC or average wholesale price (AWP).5
Fair market value
Each fee must reflect fair market value, a term HHS specifies through rulemaking.5 CMS's proposal: the cost of the service plus a reasonable markup.6
Oversight
HHS, consulting OIG, reviews PBM fee arrangements with makers. Sponsors may audit their PBM at least once a year.5
Disclosure
A PBM must give the sponsor a certified written explanation within 30 days of finalizing a manufacturer contract whose rebates or payments depend on coverage, formulary placement or utilization management (rules such as prior approval) of other drugs.5
Rebates
Rebates can continue, even as a percent of price, if they pass fully through to the sponsor.5
Employer plans follow a different path. For plan years beginning 30 months after enactment, effectively January 1, 2029 for calendar-year plans, a PBM contract entered or renewed from then must remit 100% of rebates, fees and other remuneration to the ERISA plan. The Act does not require remitting bona fide service fees, and it carries no explicit delinking of service fees for these plans.5,11,26,27 Commercial contracts may change sooner anyway: proposed FTC orders would bar Express Scripts and Caremark from basing fees from makers on list price in their standard offerings.16,17
A percent-of-WAC fee rises with every price increase; a flat fee stays put
Fee per bottle over five years, if a $612 WAC rises 5% a year
4.0% of WACFlat fee set at year 0
$0$10$20$30$40$31.24$24.48
Year 0Year 1Year 2Year 3Year 4Year 5
Illustrative · replace with your own numbers · The 5% is an assumption for the picture.
Show the numbers
4.0% of WAC
Flat fee set at year 0
Year 0
$24.48
$24.48
Year 1
$25.70
$24.48
Year 2
$26.99
$24.48
Year 3
$28.34
$24.48
Year 4
$29.76
$24.48
Year 5
$31.24
$24.48
A job with a date. Before January 2028, someone has to list every fee in every agreement that touches Part D, say whether it is a percent of a price, and rewrite it. Sidley's advice to makers is to assess market access activity, evaluate the effect on government price reporting, and watch for rulemaking.11 Built from PDFs, that list means re-reading every contract.
07 · Notice windows
How to compute an evergreen notice deadline, and what a missed one costs a drug maker
In shortThe last day to give notice is the term's end date less the notice days. That sum is easy; the traps sit around it: holidays and weekends, sent versus received, the delivery method, and which amendment's clause applies on that date. Miss it and the old deal runs for another year, including any term you wanted to change.
An evergreen clause keeps a contract alive until someone ends it. A legal guide puts the usual window for general contracts at 30 to 60 days before renewal,3 and payer contracts in our example use 60 or 90. A team wants the longer window because re-bidding a rate takes time: the company in our example asks for 90 days so the deal desk has a full quarter.
Summitview's window closes on a federal holiday, 90 days before the term ends
Jan 11, 2024Term begins
Three-year agreement, renewing yearly.
Oct 7, 2026Today
Five days left.
Oct 12, 2026Last day for notice
January 10, 2027 less 90 days. Columbus Day.
Jan 10, 2027Term ends
If notice went out.
Jan 10, 2028End of the renewal
If nothing went out, one more year on the same terms.
Fictional example from this guide
Show the numbers
When
What
Jan 11, 2024
Term begins
Oct 7, 2026
Today
Oct 12, 2026
Last day for notice
Jan 10, 2027
Term ends
Jan 10, 2028
End of the renewal
Five traps around an evergreen notice date
Check
Why it matters
In the example
Holidays
A courier or the other side's mailroom may be closed. Federal offices are, on the second Monday in October.28
October 12, 2026 is Columbus Day. Send it sooner.
Weekends
Does the clause roll a deadline forward or back? Many say nothing.
60 days before December 31, 2026 is Sunday, November 1
Sent or received
"Prior written notice" may run from receipt, under the notices section.
Allow for delivery, and keep proof of it
Method
The notices section names how and to whom.
Courier and email, to a named officer
Which clause governs
An amendment's new notice period may start only on its effective date.
Northgate moves from 90 days to 60, from January 1, 2027
What one extra year at Summitview's old fee costs
We found no published figure for how often makers miss these dates or what it costs them. You can work out your own exposure with the gap between the terms you have and the terms you would have sought. Summitview's fee is 4.5% against the company's 4.0% limit, on a $220 million contract. If the fee ran on all of that gross, half a point would come to $1.1 million for the extra year.
On a $220 million contract, each quarter point of fee is $550,000 a year
One extra year at a fee above target, assuming the fee applies to all gross sales
0.25 point above target$550K
0.50 point above target$1.1M
1.00 point above target$2.2M
Illustrative · replace with your own numbers · Arithmetic on the example's $220M. Real fees apply to eligible units only, and a rate gap may count for more.
Show the numbers
Fee gap
Cost of one renewed year
0.25 point above target
$550K
0.50 point above target
$1.1M
1.00 point above target
$2.2M
08 · Amendments
Finding the terms in force when a payer agreement has been amended four times
In shortAn amendment says "Section 4.2 is deleted and replaced". To know a rate, you apply every amendment in order to the base agreement, and you keep the old values with their dates, because a payment for last quarter runs on last quarter's terms. Most mistakes come from reading the latest document alone.
One rate can take four documents to read
Northgate Health Plan's agreement with Northwind, in order
1Base agreement
Effective January 1, 2025. Term to December 31, 2026; 90 days' notice; 24-month audit look-back.
Signed
2Amendment No. 1
An earlier change, read together with the base.
Signed
3Amendment No. 2
Deletes and replaces section 4.2. Dravenzo from 30.0% to 38.0%, exclusive. Effective January 1, 2027.
Northgate signed October 6, 2026
4Pricing record
Today's Best Price and AMP, needed before the maker countersigns.
Maintained by government pricing
5Terms in force
Old values to December 31, 2026, new values from January 1, 2027, kept with their dates.
The answer
Fictional example from this guide
Show the numbers
Step
What happens
Who
Time
Base agreement
Effective January 1, 2025. Term to December 31, 2026; 90 days' notice; 24-month audit look-back.
Signed
Amendment No. 1
An earlier change, read together with the base.
Signed
Amendment No. 2
Deletes and replaces section 4.2. Dravenzo from 30.0% to 38.0%, exclusive. Effective January 1, 2027.
Northgate signed October 6, 2026
Pricing record
Today's Best Price and AMP, needed before the maker countersigns.
Maintained by government pricing
Terms in force
Old values to December 31, 2026, new values from January 1, 2027, kept with their dates.
The answer
Ten values that change in one three-page amendment
Term
Before
From January 1, 2027
Why someone cares
Dravenzo position and rate
Preferred (parity), 30.0% of WAC
Exclusive, 38.0% of WAC
Best Price
Exclusivity conditions
None
Sole preferred brand; patients must try only generics first; prior authorization (the plan's pre-approval) no stricter than the label
Why last quarter's rebate needs last quarter's rate
Rebates are paid long after the quarter they cover. A second-quarter rebate paid in October runs on the terms in force in the second quarter, even if an amendment changed the rate on July 1. In the example, Crestline Rx's Amendment No. 3 took effect July 1, 2026 and moved Veltrimab's rate, so that October payment must use the earlier value. A spreadsheet row that was overwritten has lost the answer.
Audits reach back further still: 24 to 36 months in the example, and 12 quarters of possible pricing revisions under federal rules.20
Effective date against signature date. Northgate's amendment is signed in October but changes nothing until January. Ask of every clause: on the date this duty falls, which document was in force? Take the notice period above. A 60-day notice period written into an amendment effective January 1, 2027 may not govern a notice given in November 2026, when the older 90 days applies. A lawyer should settle it, and a reader should at least see that it is a question.
09 · Checking payments
Testing a rebate payment or fee invoice against the clause: rate, base and exclusions
In shortEvery payment is a rate times a base, less any exclusions. Each of the three can be wrong, and rebate validation needs a different source to prove each one. Payers bill from their own fee schedules, and a rebate engine pays what it is set up to pay, so a wrong rate can repeat for years until someone re-reads the clause.
Payment
What was wrong
The clause
Arithmetic
Over
Crestline Rx, Q2 administrative fee, paid October 1
Rate. Billed from its standard fee schedule
§6.1, 4.0% of WAC
4.5% × $310.0M = $13.95M; owed $12.40M
$1.55M
Alder Benefit Partners, Q2 rebate, paid October 2
Exclusion. 340B units paid
§3.4 excludes 340B units at claim level
1,180 units × $612 × 24.0%
$173K
Marlowe Specialty Pharmacy, August service fee, paid October 5
Rate. Taken from a 2025 proposal never signed
§6.1, 2.25% of WAC
2.50% against 2.25% on $34.2M
$85K
Fictional. Marlowe's figures appear as rounded on the example's screens ($854K and $769K).
One wrong rate is most of the $1.81 million paid above the clauses
Three October payments, amount over the clause, $ millions
Crestline Rx, fee rate1.55
Alder Benefit Partners, 340B units0.173
Marlowe Specialty Pharmacy, fee rate0.085
Fictional example from this guide
Show the numbers
Payment
Over
Crestline Rx, fee rate
1.55
Alder Benefit Partners, 340B units
0.173
Marlowe Specialty Pharmacy, fee rate
0.085
Where the base goes wrong: 340B units, plan switching and units of measure
The base is the harder part. Federal law prohibits duplicate discounts, the same unit discounted through 340B and rebated through Medicaid,21 and commercial contracts often exclude 340B units as well. Finding them needs claim-level data with a 340B marker, while Medicaid invoices arrive at summary level, and 340B and Medicaid run on separate systems.4
From January 1, 2027, unless a court stops it, a revised pilot lets approved makers pay 340B discounts as rebates on selected drugs. Covered entities, the 340B providers, send claim data within 45 days of dispensing and makers answer within 10. That adds a new clock and a new data stream.18,19
Older accounts name other causes that still ring true.29
Plan switching
Two PBMs invoice one drug
A member switches plans, and both PBMs invoice the same drug.
Units of measure
A decimal in the wrong place
Decimal errors in units of measure change the amount owed.
Mixed claims
One system for two lines of business
One system handles commercial and Part D claims and produces mispriced or duplicate submissions.
That article, from 2008, was written by an executive at a rebate software company, so read its estimate of a 3% to 5% error rate as an old vendor view.
The dispute window that turns an overpayment into a recovery
A finding has value only if it can still be acted on. Contracts usually set a dispute window: 90 days from the invoice in the example, and 60 at the low end of what the company accepts. Past that, an overpayment may have to wait for an audit, if the contract grants one. Keep the window, the invoice date and the clause together, and an overpayment becomes a simple deduction from the next invoice.
One law firm reports cutting a PBM aggregator's multi-million-dollar rebate invoice to a manufacturer by more than 83% before litigation, and advises makers not to pay such invoices without review.30 It is the firm's own account of its own case, and a sign of how large these disputes can be.
10 · What goes wrong
The common payer contract errors, and the Best Price cases that show the stakes
In shortCommercial errors cost money you can often recover. Pricing errors can turn into cases under the False Claims Act, the federal law against false claims on government money. Large federal settlements on Medicaid rebates have turned on discounts left out of Best Price. Most everyday errors share one cause: the signed words and the systems that pay are maintained apart by different people.
Discounts left out of Best Price have cost makers hundreds of millions
Federal settlements involving Medicaid rebate underpayment
Wyeth and Pfizer, 2016: bundled discounts left out of Best Price$784.6M
Merck, 2008: hospital discounts left out of best prices, and payments to physicians$650M
Aventis, 2009: private-label deal with an HMO$95.5M
Source31,32,33 · Settlements resolve allegations. Merck's total is more than $650 million and covers more than rebates. All are older cases.
Show the numbers
Case
Settlement
Wyeth and Pfizer, 2016: bundled discounts left out of Best Price
$784.6M
Merck, 2008: hospital discounts left out of best prices, and payments to physicians
$650M
Aventis, 2009: private-label deal with an HMO
$95.5M
Federal law adds its own penalties for reporting. The statute says up to $100,000 for each item of knowingly false information and $10,000 a day for late data.2 Adjusted for inflation, those maximums now stand at $236,451 and $23,647.34 Pricing reports must be certified by a CEO, a CFO or someone with equivalent or delegated authority.20
Where each payer contract error first shows up
Most contract errors are invisible on the invoice and visible only against the clause
RarelySometimesUsually
On the invoiceIn the rebate systemAgainst the clauseIn an auditFee billed from a schedule or unsigned proposalRarelyRarelyUsuallySometimesRate not updated after an amendmentRarelySometimesUsuallySometimesSuperseded rate paid for a new periodRarelySometimesUsuallyUsually340B units rebatedRarelySometimesSometimesUsuallySame claim invoiced twiceSometimesSometimesRarelyUsuallyFormulary condition no longer metRarelyRarelySometimesUsuallyNotice date missedRarelyRarelyUsuallyRarelyBest Price effect not reviewedRarelyRarelySometimesUsually
How confident pricing leaders say they are, and what that leaves out
In a 2026 survey of 429 US leaders at pharmaceutical and medtech companies with revenue above $250 million, 99% said managing rebates, discounts, chargebacks and government obligations had grown harder, and 61% named PBM demands as a top contributor. 94% said they were confident their government pricing reports would withstand an audit.35 A vendor of revenue management software commissioned the survey. Confidence in the report is a separate matter from confidence in the contract terms that feed it.
Finance
Accruals built on the wrong rate
Rebates and chargebacks reduce revenue as estimates, which companies must check against actual amounts each period.36 A rate that never reached the accrual model becomes a true-up later. Public companies also report on internal control over financial reporting.37
Access
Paying for a position you lost
Vendor research points to formulary position: skip the check of where a product sits before paying, and overpayment becomes more likely.9
Patients
Who bears a high list price
GAO notes that Part D cost-sharing rests on the gross price, so members on highly rebated drugs may pay more at the counter.7 Contract terms shape that, which is one reason rebates draw attention in Washington.
11 · Market and trend
How large gross-to-net has become, and how rebate contracts are changing shape
In shortGross-to-net is the gap between a drug's sales at list price and what its maker keeps. The trade analyst Drug Channels estimates brand gross-to-net reductions at $416 billion for 2025. Large PBMs are now moving toward fees and discounts at the pharmacy counter, so contract forms will change while the money stays large. Rebate leakage figures come from vendors, and we found no published rates of missed dates or overpaid invoices.
Gross-to-net reductions on brand drugs passed $400 billion in 2025
Estimates by year; methods and scope changed along the way
$75B2012
$236B2021
$356B2024
$416B2025
Source4,38,8 · From 2024, Drug Channels' figure also takes in off-patent brands facing generics, so years are not strictly comparable. 2012 and 2021 are as Pharmaceutical Commerce reported them. Gross-to-net covers rebates, discounts, fees and patient support.
Show the numbers
Year
Reductions
2012
$75B
2021
$236B
2024
$356B
2025
$416B
$48.6B
in Part D rebates in 2021, 23% of $210.6 billion of gross spending.7
GAO, September 2023
84%
of those Part D rebates, $40.9 billion, were on 100 brand drugs.7
GAO, September 2023
2–3%
of revenue lost to rebate leakage at a mid-sized maker, by one vendor's 2021 research.9
MMIT, a vendor of rebate validation; another MMIT paper says 2–3% of rebates
About a third of the 2024 gross-to-net total comes from 340B and Medicaid
About 1 in 3
dollars of 2024 gross-to-net reductions are 340B discounts and Medicaid rebates; most of the rest is rebates to third-party payers. The source says "about one-third".
dollars of 2024 gross-to-net reductions are 340B discounts and Medicaid rebates; most of the rest is rebates to third-party payers. The source says "about one-third".
33 of 100
From rebates to fees: what large PBMs have announced
Express Scripts
Rebate-free, optional
Cigna said on October 27, 2025 it would build discounts into the price at the counter, starting with fully insured members in 2027 and commercial clients in 2028. Drug Channels reads this as optional, and Cigna expects about half of commercial business to move by the end of 2028.39
Optum Rx
Per-member fees
In May 2026 it announced a fee-based model using per-member monthly fees, with pricing no longer tied to list prices or prescription volume.40
Caremark
Offer without rebates
Under its proposed FTC settlement of July 14, 2026, it would have to offer plan sponsors a standard arrangement that excludes rebates, and pass through rebate savings.23,17
Each of these models still runs on a signed clause, and each means more versions of the same deal, more amendments, and fee clauses that must be found and rewritten.
What we could not find published. We found no public figure for how long a payer amendment takes to abstract, how often notice dates are missed, what share of fee invoices differ from the clause, or how much overpayment makers recover. Vendor figures come without a dataset, and we found no independent test of the 2–3% leakage figure. Your own numbers are the ones to use. Part C says how to find them.
12 · AI and controls
What AI can read in a rebate contract, what stays with people, and which rules apply
In shortReading clauses, reconciling amendments and recomputing payments can all be checked line by line, so they suit automation. Fair market value, whether to renew and what to do about a Best Price flag are judgments that belong to named people. The rules that apply here are financial and pricing controls; FDA's AI and quality-system guidance largely address other work.
Automate what a person can check against a clause; keep judgments with people
Cost of a wrong answer →
People decide
Person confirms
Leave for later
Automate first
Linking a document to its agreementReading datesReading a ratePayment checkDrafting a noticeFair market valueRenew or not
Ease of checking the result against the clause (0–1)
Cost of a wrong answer (0–1)
Linking a document to its agreement
0.72
0.12
Reading dates
0.76
0.30
Reading a rate
0.76
0.54
Payment check
0.80
0.74
Drafting a notice
0.38
0.64
Fair market value
0.12
0.80
Renew or not
0.10
0.52
Which rules reach an AI reading payer contracts
Financial and pricing controls apply; drug and device quality guidance mostly does not
Outside its scopeDepends on your useApplies
Reach over payer contract work42 CFR 447.510: pricing records and certificationAppliesSarbanes-Oxley section 404: internal control report, for public companiesAppliesRevenue estimates under ASC 606, the US revenue accounting standardAppliesFDA draft guidance on AI for regulatory decisions (January 2025)Outside its scopeFDA Computer Software Assurance guidanceOutside its scopeEU manufacturing rules: GMP Annex 11 and draft Annex 22Outside its scope
Sarbanes-Oxley section 404: internal control report, for public companies
Applies
Revenue estimates under ASC 606, the US revenue accounting standard
Applies
FDA draft guidance on AI for regulatory decisions (January 2025)
Outside its scope
FDA Computer Software Assurance guidance
Outside its scope
EU manufacturing rules: GMP Annex 11 and draft Annex 22
Outside its scope
Rule or guidance
What it covers
What that means here
FDA draft on AI, January 2025
AI that produces information for regulatory decisions on a drug's safety, effectiveness or quality. The page still reads draft.41
A payer rate is a commercial term. Its credibility framework is still a useful way to think about context of use.
FDA Computer Software Assurance
Software in medical device production and quality systems. Final; the current version is dated February 3, 2026.42
It addresses device software, so it does not reach payer contracts. Its risk-based testing idea can inform your own.
Draft EU GMP Annex 22
AI in medicines manufacturing, still a draft in November 2026, after a July to October 2025 consultation; it says generative models should not be used in critical GMP applications.43,44
US payer contracts sit outside good manufacturing practice (GMP), so it does not apply here.
Pricing records
10 years of data and materials behind AMP and Best Price, including assumptions.20
If a tool informs a pricing decision, keep what it read, what it concluded and who decided.
Internal control report
Management's yearly assessment of financial reporting controls, at public companies.37
Treat automated rate changes as a control: who approved, what changed, what test proved it.
Limits a buyer should expect in contract abstraction
Reading software fails in known ways. A scanned table loses a column. A defined term points to a schedule no one supplied. An amendment cites a section that does not exist. A clause says "reasonable" and leaves the number to argument. A good system marks these and asks a person. It also reads only what it is given, so a side letter (a separate note that changes a term) sitting in someone's inbox stays invisible.
In the 2026 survey, 97% of leaders say they use AI in some capacity,35 which tells you little about whether it is checked. Ask to see the checking.
13 · How teams do it today
How contract operations, the deal desk, gross-to-net finance, government pricing and legal share a payer contract today
In shortFive groups touch every amendment, and the signed copy is often re-keyed into several systems by hand. Dates go to personal calendars. Finance pays from the rebate engine, and few people re-read the clause. Teams run this in house, with outsourced rebate processing, or with revenue management and contract software, and most mix all three.
The five people who answer for a payer agreement
CO
Contract operations
Logs the signed copy, abstracts terms, keeps the file, chases data files.
Cares about: where that date came from, when someone asks.
DD
Deal desk or contract strategy
Negotiates rates, decides renewals and notices.
Cares about: the deadline early, with the clause in front of them.
RA
Gross-to-net and revenue accounting
Validates invoices, pays, accrues, disputes.
Cares about: what was paid that the contract does not support, in time.
GP
Government pricing
Calculates AMP and Best Price, tests fees, reports to CMS.
Cares about: seeing a rate before it is signed.
LG
Contracts counsel
Owns standard positions, approves exceptions, signs off on notices.
Cares about: a reason for every exception.
Hand-offs from a signed amendment to terms in the rebate engine
An amendment changes hands five times before it reaches a payment
1Logged
Signed copy arrives by e-signature or mailbox, and is linked to its agreement.
Contract operations
2Abstracted
Terms typed into a spreadsheet or contract system, with clause references if time allows.
Contract operations
3Reviewed
Compared to standard positions and the approved deal; Best Price and fee review.
Legal, government pricing
4Dated
Dates added to shared and personal calendars, with owners.
Contract operations, deal desk
5Keyed
Rates entered in the rebate engine, pricing calculation and accruals.
Signed copy arrives by e-signature or mailbox, and is linked to its agreement.
Contract operations
Abstracted
Terms typed into a spreadsheet or contract system, with clause references if time allows.
Contract operations
Reviewed
Compared to standard positions and the approved deal; Best Price and fee review.
Legal, government pricing
Dated
Dates added to shared and personal calendars, with owners.
Contract operations, deal desk
Keyed
Rates entered in the rebate engine, pricing calculation and accruals.
Revenue accounting, IT
Reading and reconciling take about half of an amendment's days by hand
An estimated split of 10.5 working days for one payer amendment
LoggingAbstractingReconcilingReviewingDates and keying
One amendment by hand1 day3 days2 days2 days2.5 days
Illustrative · replace with your own numbers · An estimate, with no public benchmark behind it. Time five of your own.
Show the numbers
Logging
Abstracting
Reconciling
Reviewing
Dates and keying
One amendment by hand
1 day
3 days
2 days
2 days
2.5 days
In house, outsourced or software: three ways to run payer contracting
In house
Your team, your spreadsheets
Full control and deep knowledge of each payer. Knowledge leaves when people do, and checks shrink as volume grows.
Outsourced
A rebate processing service
A service validates and pays invoices. It works from the terms you hand it, so the reading problem stays with you.
Software
Revenue management and contract systems
Revenue management software calculates and adjudicates. Contract lifecycle software stores and tracks. Someone still has to put the terms in, correctly, with their clauses.
Part B · See it working
Botminds Payer Contract Management: one October at a mid-sized drug maker with 20 payer agreements
Part A described the work without naming a product. This part shows how Botminds does it, at Northwind Bio, a fictional US maker of three brands. Every company, person, number and document on these screens is sample data, and the contract text is sample text written for the example.
14 · One October, start to finish
A $1.55 million fee overpayment, a notice with five days left and a new Best Price on Dravenzo, all in one morning
In shortThis is the example from the top of the page, inside the product. On Wednesday, October 7, 2026, the contract team opens its calendar. Revenue accounting opens a recovery claim, the deal desk sends a notice drafted from the clause, and government pricing reviews a new amendment before anyone countersigns it. Agents do the reading and the arithmetic. People decide.
1
October's 42 duties, each read from its clause
Dana Okafor, the contract operations lead, opens the month. Forty-two obligations from 20 contracts sit on their days, colored by kind: notice deadline, term and renewal, price protection, audit window, data due, payment due, fee review. Thirty-one are open. One chip is solid red, and three days carry a flag.
Hover over any chip and the payer, the duty and the owner appear. Click it and its clause opens. Northgate Health Plan's new amendment is waiting too, marked on today's date.
The obligation calendar. Every dated duty from every contract on its day, with the month's counts on top.
2
Crestline billed 4.5%; section 6.1 says 4.0%
At 7:04 am the payment checker recomputed six October payments from the clause in force, and three differ: $1.81 million above the clauses. Lena Ortiz, in gross-to-net and revenue accounting, opens the largest. Crestline Rx billed its second-quarter administrative fee at 4.5%, the rate in its standard fee schedule, on $310.0 million of eligible sales. That comes to $13.95 million against $12.40 million owed.
The screen shows the clause text and the 90-day dispute window. Lena opens a recovery claim for $1.55 million, deducted from the next invoice. The checker never changes or holds a payment on its own.
Paid differently from the clause. What the clause says, what was paid, the basis, the clause text, who decides and the dispute window.
3
Summitview's notice, drafted from sections 12.1 and 12.2
The red chip is Summitview Rx, a $220 million agreement. Its term ends January 10, 2027, section 12.2 asks for 90 days' written notice, and the last day is Monday, October 12. Its 4.5% administrative fee is outside the company's playbook, the list of standard positions kept by Legal. Sam Patel, on the deal desk, opens the draft, dated the day it will go out.
He signs and sends it by courier and email, as the notices section requires, with Priya Ranvelle in Legal copied. He could instead let it renew, with a recorded reason. Reminders reached him 30, 14 and 7 days before. A team that also wants a margin for the federal holiday can set its own.
Notice not to renew. The letter drafted from the clause, for a named person to sign and send.
4
Amendment No. 2 would set a new Best Price
Northgate Health Plan signed Amendment No. 2 on October 6, and it arrived at 8:12 am through the e-signature envelope. Six agents read it against the base agreement, Amendment No. 1, the playbook and the pricing record: 24 terms, 10 changed values, 4 variances and 6 proposed duties.
The price impact checker works the numbers. At 38.0% of a $612 list price the lowest net is $379.44, below today's $409.42. The Medicaid unit rebate rises from $151.78 to $181.76 on about 118,400 units, about $3.55 million more a quarter. If the 5.5% fee fails the service fee test, the lowest net is $345.78. Omar Haddad, the government pricing manager, sees all of it before countersignature.
The Best Price check. The arithmetic line by line, with the fee finding below it. The screen counts the Medicaid effect; section 5 explains the 340B effect, which your pricing team would add.
5
Signed, published, six new dates on the calendar
Dana confirms the 24 terms beside the signed copy and routes the amendment to pricing review. Omar signs with the meaning of his signature on the screen and a note for the record: the exclusive access is worth the Medicaid effect per the deal model, and the fee must carry a fair-market-value study before January 1 or be capped at 4.0%.
Dana publishes. Terms go to the rebate engine, with a test calculation, to the pricing calculation and to the accruals in the finance system (ERP). Six duties go live with owners. The first, November 2, rests on the amendment's new 60 days; counsel would confirm which notice clause governs before the January 1 effective date.
Live, with its dates. The amendment's six duties, each with an owner, a clock and a link to its clause.
Screens are shown with US dates and times. The dashboard's figures are sample data. Design targets are given in section 17.
15 · Every screen
The rest of the screens, from a 340B variance to the clause playbook and the approvers' settings
In shortThe story above touches five screens. These show the rest: the other two variances, the choice to let a contract renew, the book of agreements, terms beside the signed copy, each changed value, the sign-off, the publish, the record of who did what, every obligation, the playbook, the dashboard and your settings.
The next notice deadline. Beside the month: the clause, the term end, what it covers, the fee finding and who decides.
Claim opened. Crestline's flag turns to claim opened, and $258K waits on Lena's decision.
340B units paid. The claim file flagged 1,180 units with the 340B identifier, and section 3.4 excludes them: 1,180 × $612 × 24.0% = $173K.
A rate from an unsigned proposal. Marlowe invoiced 2.50% from a 2025 fee proposal. Section 6.1 sets 2.25%.
Let it renew, with a reason. Silence becomes a choice someone made and wrote down.
Pricing sign-off. The meaning of the signature, a note for the record, the signer and the time, written to the audit trail.
The contract shelf. One spine per agreement, grouped by kind of payer. Width shows gross sales, color shows stage, and the badge counts playbook variances.
The book of agreements. Each agreement's latest document, stage, gross a year, next clock and variance count.
Agents at work. Each step and what it found, as it runs, including the Best Price warning.
The activity record. Who did what and when, agent or person, starting with the deal sheet Sam approved on September 18.
Terms, each with its clause. Every term beside the highlighted signed copy, with a confidence, its clause and the value it replaces. Price terms always need a person.
What changed. Ten values, old beside new, from January 1, 2027. Old values stay on file with their dates.
Findings and passes. The other checks by severity, including the passes: rates against the approved deal sheet, 340B exclusion, fallback rate.
Publishing. Approved terms to each system, with the test calculation that proves the rate landed.
Your approvers and reminders. Who decides each thing, what may be confirmed without a person, and when people are reminded.
Every obligation. Each duty with its clock, kind, payer, clause and owner, ready to export to a calendar.
The clause playbook. Where each variance sits across the agreements, and each rule's standard, fallback and walk-away. Rule PB-01's note says a fee above fair market value counts in AMP and Best Price; section 6 explains why a fee to a PBM may be treated differently.
The dashboard. Documents, days to live, terms confirmed as read and duties on time. All figures are sample data.
Systems and people. Where approved terms go, and each person's role.
Select any screen to open it larger. Companies, people, contract text and figures are fictional.
16 · Agents, and who decides
Eight agents read and check payer contracts; five named people decide every term, notice and variance
In shortSix agents run when a signed copy arrives, the payment checker runs on each payment, and the term publisher runs only after approval. Each has one job and limits it cannot cross. None confirms a price term, sends a notice or moves a payment. Separate people confirm, sign and publish, and each action lands on the audit trail.
Contract intake
Takes signed contracts from the e-signature envelope and the contracts mailbox, decides agreement, amendment or side letter, and links each to its agreement, payer and products. Anything it cannot match goes to a person.
Term abstractor
Reads every clause, table and defined term, and fills each term with a value, a confidence and its clause. An ambiguous value is marked and sent to a person.
Amendment reconciler
Applies each amendment to the base and earlier amendments, so the terms in force on any date are known. Flags any cited section that does not exist. Keeps old values with their dates.
Playbook checker
Compares each term with standard, fallback and walk-away, and rates and dates with the approved deal sheet. Only Legal changes the playbook.
Price impact checker
Works out the lowest net each term allows against Best Price, tests whether each fee can stay a bona fide service fee, and shows the Medicaid effect and price protection exposure. It changes no pricing figure.
Obligation tracker
Turns notice, renewal, price protection, audit, data, payment and fee clauses into dated duties with owners, using confirmed clauses only. Scans them each morning. Reminders stay inside the company.
Payment checker
Recomputes each rebate payment, fee invoice and chargeback credit from the clause in force for its period: rate, eligible units, exclusions, fee caps. Flags differences above your threshold, with the arithmetic.
Term publisher
Sends approved terms to the rebate engine, pricing calculation, ERP accruals and contract system, then proves the test calculation matches. On a mismatch it stops and alerts contract operations.
Who confirms, who signs and who publishes a payer amendment
Confirms and publishesDana Okafor, contract operationsChecks terms beside the signed copy. Price terms always need a person. Publishes approved terms once.
Decides noticesSam Patel, deal deskSigns each notice or records why a contract renews.
Decides variancesLena Ortiz, revenue accountingOpens a recovery claim or accepts the difference, with the choice on record.
Signs before countersignatureOmar Haddad, government pricingApproves or holds any term below Best Price, and any fee above the cap or without a study, with an e-signature that records its meaning.
Owns positionsPriya Ranvelle, LegalApproves each variance outside the playbook and each playbook change, versioned: version 4, approved September 2, 2026 in the example.
The names are fictional, from the sample data.
17 · Inputs, outputs, targets
Signed contracts and payment files go in; cited terms, an obligation calendar and variance flags come out
In shortThe solution reads what contract teams already hold and feeds the systems they already run. It is built for enterprise use: roles and separation of duties, maker-checker (one person confirms, another approves) on every price term, a full audit trail, and links to your rebate engine, pricing calculation, ERP and contract system.
From your contract file
Executed agreements, amendments and side letters
Clause playbook: standard, fallback, walk-away
Approved deal sheets
Product master with National Drug Codes
From finance and pricing
Rebate payments, fee invoices and chargebacks
Claim-level utilization files, with 340B identifiers
Pricing record: AMP and Best Price by product and quarter
Agents read, reconcile and checkEvery document and every payment, against the clause in force, under your playbook
A person confirms every price term
Every term and date cites its clause
Outputs
Obligation calendar: every dated duty with its clause and owner
Variance flags: paid against the clause, with the arithmetic
Structured, cited terms in force on any date
Notices and recovery claims drafted from the clause
Approved terms fed to the rebate engine, pricing calculation and ERP
What changes for the team
Terms to confirm, each beside its passage
A rate seen by pricing before countersignature
A list of every fee to rewrite before 2028
Fits the rebate engine, pricing and ERP systems you already run
Signed copies arrive from your e-signature system or a contracts mailbox. Approved terms go to your rebate engine, government pricing calculation, ERP accrual model and contract repository, with your approvers set in the settings. Security: SOC 2 Type II audited, information security managed to ISO 27001. Controls here support your own compliance programs, and the responsibility for pricing reports stays with your certifying officers.
Design targets for dates, days and payments checked
52 of 52
notice, data, payment and audit dates met on time in a quarter.
Design target, to be measured on your contracts
2.1 days
median from a signed copy arriving to its terms live in every system, against an estimated 9 to 12 by hand.
Design target, and our estimate
100%
of rebate and fee payments checked against the clause in force.
Design target
Part C · Are you ready to automate?
Payer contract management software: what slips cost you, what automation could return and how to test it
You run market access contracts, or pay against them, or sign the pricing reports they feed. This part is written for you: what errors and missed dates cost today, what automating the reading and checking could return, whether your team is ready, and what to ask any vendor, including us.
18 · What slips cost you
What missed notices, overpaid fees and unseen Best Price effects cost a market access team
In shortStart with your own numbers, because no public figure tells you how often these errors happen. The published figures that exist describe the size of the stakes: federal penalties per false item, past settlements, and one vendor's estimate of leakage. Each cost below can be measured from your own files within a week.
$236K
maximum federal penalty for each item of knowingly false pricing information, and up to $23,647 a day when data is late. The statute's $100,000 and $10,000 are adjusted for inflation.2,34
42 U.S.C. 1396r-8(b)(3)(C); 45 CFR 102.3
$784.6M
paid by Wyeth and Pfizer in 2016 over discounts allegedly left out of Best Price.31
Announced by the US Department of Justice, 2016
12 quarters
of pricing revisions are possible, and 10 years of records must back them.20
42 CFR 447.510
Most of an amendment's days are reading, reconciling and review, which is what software can shorten
Working days for one payer amendment, signed copy to terms live
By hand (our estimate)With automation (design target)
Logging and linking the signed copy1 day0.1 days
Abstracting rates, tiers, fees and dates3 days0.4 days
Reconciling with the base and amendments2 days0.2 days
Playbook, Best Price and fee review2 days0.8 days
Dates, owners and reminders on the calendar1 day0.1 days
Keying terms into downstream systems1.5 days0.5 days
Illustrative · replace with your own numbers · Neither column is a measurement. They total 10.5 and 2.1 days. Time five of your own amendments, and measure the target in a pilot.
Show the numbers
By hand (our estimate)
With automation (design target)
Logging and linking the signed copy
1 day
0.1 days
Abstracting rates, tiers, fees and dates
3 days
0.4 days
Reconciling with the base and amendments
2 days
0.2 days
Playbook, Best Price and fee review
2 days
0.8 days
Dates, owners and reminders on the calendar
1 day
0.1 days
Keying terms into downstream systems
1.5 days
0.5 days
Five amendments, ten payments and a list of renewals: a week to your baseline
Cost
Where it hides
How to find your number in a week
Overpaid fees
Fee invoices paid from the payer's schedule
Take your ten largest fee invoices of last quarter and recompute each by hand from the clause in force
Overpaid rebates
340B units, rates after an amendment, duplicate claims, lost formulary position
Recompute ten rebate payments, one from each kind of payer, using claim-level data
Missed or near-missed notices
Contracts that renewed with no decision on file
List every renewal in the last 24 months and find the decision behind each
Lapsed disputes
Errors found after the window closed
Ask finance for findings from the last year, and which could still be recovered
Abstraction time
Reading, keying and re-checking across five teams
Log hours and elapsed days on the next five amendments
Pricing surprises
Rates reviewed after countersignature
Count the last 20 signed amendments and how many reached government pricing first
Part D fee rewrite
Percent-of-WAC fees in agreements touching Part D
Try to list them. The time it takes is the number
The re-bid you never ran, and other costs of a contract nobody re-read
The re-bid you never ranA renewal on old terms hides the better deal you might have struck.
The audit answer that takes a monthA payer asks where a rate came from, and three people go looking through email.
The rate that outlived the personWhen a contract lead leaves, so do the reasons behind each exception.
The restatementA Best Price correction reaches back through quarters of reports and rebates.
Your team's attentionHours spent keying rates that could go to re-negotiating them.
19 · Your return
What checking every payment returns: recoveries, renewals you chose and hours saved per amendment
In shortPut in your own numbers. For most teams hours saved are the small part. Overpayments found inside the dispute window and renewals you decide on purpose are the large ones, and both rest on rates only you can measure. Every default marked illustrative is an assumption to replace.
Recoveries, renewals and reading time: where a contract team gains
Payments
Overpayments found in time
Every payment recomputed from the clause in force, inside the dispute window.
payments a year × share overpaid × share recovered
Renewals
Notices you meant to send
Each deadline reaches its owner with the clause and a draft in hand.
renewals avoided × cost of one extra year
Reading
Hours per document
Terms arrive cited, and people confirm them instead of keying them.
documents × hours saved × loaded hourly cost
Pricing
Flags before signature
Government pricing sees the lowest net before anyone countersigns.
Medicaid and 340B cost of each flag you would have renegotiated
Fee rewrite
A 2028 worklist
Every percent-of-WAC fee listed from the terms already read.
hours to build the list today, minus hours with terms on file
Audit
Answers on request
Each term, date and decision opens its clause and its signer.
hours spent assembling support for audits and reviews
Your payments, overpayment rate, documents and missed notices
We found no public figure for any of these inputs, so every default is an assumption for you to replace. The renewal cost default is the half-point example from section 7.
PaymentsRenewalsReadingYour cost
Illustrative yearly value
Overpayments recovered$0
Unwanted renewals avoided$0
Reading hours released, valued$0
After your yearly cost$0
Overpayments to find a year to cover your cost by themselves$0
Formulas, per year: Recovered = payments × share overpaid × share recovered Renewals = renewals avoided × cost of one year Reading = documents × (hours today − hours with automation) × hourly cost After your cost = the three added, less yearly cost Overpayments to find = yearly cost ÷ share recovered
Not counted: Best Price effects seen in time, audit hours, the Part D fee rewrite and faster answers. Hours released are value only when you decide what they are for. A vendor's estimate puts leakage at 2–3%;9 the 0.5% default sits well below it because that figure is unverified.
The overpayment rate decides the case, and it is the number you have not measured
Recoveries a year on $900 million of payments, recovering 60%
0.1% overpaid$540K
0.5% overpaid$2.7M
1.0% overpaid$5.4M
Illustrative · replace with your own numbers
Show the numbers
Share overpaid
Recovered a year
0.1% overpaid
$540K
0.5% overpaid
$2.7M
1.0% overpaid
$5.4M
At 0.1%, recoveries alone still cover the example's $350,000 yearly cost. If you pay only a few million a year in rebates and fees, they will not, and you should say so before buying anything. Run your ten-invoice test first.
Start here20 · Readiness check
How ready your contracting team is: agreements in scope, signed copies, playbook, payment data and sign-off
In shortPick the answer closest to your team today. Eight questions score 0 to 2, and the last is for reflection. The meter adds up your score as you go, and each question says why it matters and what a strong answer sounds like.
1
Agreements in scope
How many active payer agreements do you hold, counting amendments?
Why it mattersBelow a certain count a careful person can hold the book in their head. Dozens with yearly amendments cannot be held that way.
A strong answer"Twenty agreements, about 60 documents a year, across PBMs, plans, Part D and buying groups."
2
Signed copies
Can you put your hands on every executed agreement, amendment and side letter this week?
Why it mattersAny reader, human or software, sees only what it is given. A missing side letter makes the terms in force wrong.
A strong answer"One repository, checked against the deal desk's list last quarter."
3
Your baseline
Do you know your overpayment rate, your missed notices and your days from signed copy to terms live?
Why it mattersWe found no public benchmark for any of these, so your own baseline is the only way to prove a gain.
A strong answer"We recomputed 30 payments last year, found four wrong, and an amendment takes about two weeks."
4
Clause playbook
Are your standard, fallback and walk-away positions written down and owned?
Why it mattersA checker can only compare a contract with a position someone wrote. Otherwise it finds differences, and no one can say which matter.
A strong answer"Eight clause families, owned by counsel, versioned, and last approved this quarter."
5
Payment and claim data
Do you get payments, fee invoices and claim-level files, with 340B identifiers, in a form you can use?
Why it mattersA rate can be checked from an invoice. A base and its exclusions need claim-level data, and summary files hide the errors.4,29
A strong answer"Claim-level from our top payers, 340B flags on most, the rest under renegotiation."
6
Pricing review before signature
Does government pricing see every rate and fee before countersignature?
Why it mattersAfter signature the choices narrow. Pricing reports must rest on records and assumptions kept for 10 years.20
A strong answer"Yes, it is a step in the deal process, with a recorded decision each time."
7
One owner across five teams
Is one person accountable across market access, finance, pricing and legal, with budget?
Why it mattersThis work crosses five teams, and without one owner it stalls at the first handoff.
A strong answer"The head of contract operations leads it, with the VP of market access sponsoring and finance funding it."
8
Controls for AI in finance work
Do you have a path to approve AI that feeds rates into finance systems: internal audit, IT security, named sign-offs and a record?
Why it mattersPublic companies report on internal control over financial reporting.37 A rate that reaches accruals needs an approver and a test.
A strong answer"Internal audit has reviewed the approach, and each publish needs a named approver and a test calculation."
9
For reflection: the 2028 fee list
If your general counsel asked tomorrow for every percent-of-WAC fee in every agreement touching Part D, how long would the answer take, and what would have to be true for it to take an hour?
Why it mattersYour answer lists the gaps. Each gap is a candidate job for software: finding, reading, reconciling or checking.
A strong answerA short, specific list, for example: "every amendment on file, every term cited, every fee typed by form and by channel."
A low score usually means gathering the signed copies first
0–6
Explore
Gather every signed copy, write down your clause positions and name an owner. Recompute ten fee invoices by hand. That test tells you whether this is worth your time.
7–11
Ready to pilot
Run a measured pilot on one kind of payer and its amendments, with last quarter's payments, some planted errors and your people confirming every term.
12–16
Ready to implement
Plan all payer types, your approvers, feeds to your rebate engine, pricing calculation and ERP, the fee rewrite for 2028, and what internal audit will ask to see.
21 · Questions for any vendor
What to ask payer contract software about clauses, amendments, Best Price and payment checks
In shortAsk every vendor of contract management software for pharma the same questions, us included. The answers show what the tool reads, how it handles amendments, whether it understands pricing rules, how it checks payments and who stays in charge.
Ask
A good answer
A warning sign
Reading contracts
Can you show the passage behind every term and date?
One click from the value to the highlighted clause in the signed copy
A confidence score alone
How do you handle tables, defined terms, schedules and scanned pages?
Reads them, and marks what it cannot read for a person
"The model handles it"
Amendments and dates
Can you give the terms in force on a date we pick, for last quarter?
Yes, with old values kept and dated
Only the latest values are stored
What do you do when a date falls on a holiday, or when an amendment's clause is not yet effective?
Shows the question, with both clauses, for a person to settle
A single date with no working shown
Pricing rules
How do you tell a plan's rebate from a PBM's, and a mail order arrangement?
Rules by counterparty, citing 42 CFR 447.505, set with our pricing team
Every rate treated the same
How do you test a fee?
Each of the four tests, marked as on file or missing, and a person decides
"AI determines fair market value"
Can you list every percent-of-WAC fee touching Part D for the 2028 rule?
Yes, from the terms on file, and updated when HHS rules
A custom services project, quoted separately
Payment checks
What do you recompute: rate only, or rate, base and exclusions?
All three, at claim level where data allows, with the arithmetic shown
Invoice totals against a rate table
Can it change or hold a payment on its own?
No. It flags, and a named person decides
Auto-adjusts "to save time"
Control and evidence
Which terms can be confirmed without a person?
Your setting. Price terms always need one
A single auto-approve threshold
What will internal audit and a pricing reviewer get?
Who did what, when, on which clause, exportable, kept to your retention
Logs on request from the vendor
What security evidence can you show?
A current audit report you may read
Claims that a product is "certified" for a regulation; products cannot be
22 · How to start
A twelve-week payer contract pilot on one payer type, last quarter's payments and planted errors
In shortStart with the kind of payer that holds your largest fees, usually PBMs. Read its agreements and amendments, recompute last quarter's payments, plant known errors, and decide on three numbers: errors caught, false alarms and hours per document. Your people keep confirming every term throughout.
Twelve weeks ends with a decision on three numbers
Your teamVendor
Gather signed copies; time five amendments
Write the playbook rules; plant errors
Set up clauses, approvers and reminders
Read agreements and amendments; confirm terms
Recompute last quarter's payments
Run the next quarter's dates in parallel
Measure and decide
Week 04812
Illustrative · replace with your own numbers
Show the numbers
Activity
From
To
Gather signed copies; time five amendments
0
2
Write the playbook rules; plant errors
1
3
Set up clauses, approvers and reminders
2
5
Read agreements and amendments; confirm terms
4
8
Recompute last quarter's payments
5
9
Run the next quarter's dates in parallel
6
11
Measure and decide
10
12
Errors caught, false alarms and hours per document on your own contracts
Measure
How
Why
Terms right as read
Sample 200 terms against the clause, split by rate, fee, date and eligibility
One average hides weak families
Planted errors caught
Plant wrong rates, 340B units and old-term payments; caught ÷ planted, per kind
Known answers make the test fair
False alarms
Flags on correct payments, in reviewer minutes
A tool that flags everything catches every plant
Real money found
Variances on real payments, confirmed by revenue accounting, inside the window
The case rests on it
Hours and days
Person-hours per document; days from signed copy to terms live
Compare with your five timed amendments
Dates on time
Duties met in the parallel quarter, against your old calendar
Shows what each calendar would have missed
The working-session questions: nine questions in three groups
Bring contract operations, the deal desk, revenue accounting, government pricing, legal and internal audit into one room. Each question says why it matters, what a strong answer looks like and the warning sign.
A
Scope: which payers, which documents, which fees
A1
Which kind of payer goes first, and why?
Why it mattersFees and rates differ by kind, and pricing treatment differs too.
Strong answer · warning sign
PBMs first for fee recovery, plans next for Best Price.
All at once.
A2
Where might side letters and unsigned proposals be sitting?
Why it mattersTerms in force are only as good as the file.
Strong answer · warning sign
A list from the deal desk and legal, checked.
"There are none."
A3
Which agreements touch Part D, directly or through a PBM?
Why it mattersThe flat fee rule applies from January 1, 2028.11
Strong answer · warning sign
A list with owners, and counsel's reading of the Act.
Waiting for the rule before starting.
B
Decisions: who signs a notice, a claim and a pricing flag
B1
Who decides each variance, and up to what amount?
Why it mattersApprovers become settings.
Strong answer · warning sign
Named roles and a threshold.
"Finance will sort it out."
B2
When does government pricing see a rate, in the deal process?
Why it mattersA flag after signature is a renegotiation.
Strong answer · warning sign
Before countersignature, every time.
At quarter end.
B3
What do we do when notice falls on a holiday or a weekend?
Why it mattersOctober 12, 2026 and November 1, 2026 are real examples.28
Strong answer · warning sign
A rule from counsel, and a margin in the reminders.
Each person decides.
C
Evidence: what audit and pricing reviewers will ask to see
C1
What must we keep, and for how long?
Why it matters10 years for materials behind AMP and Best Price, assumptions included.20
Strong answer · warning sign
A retention rule that covers the software's records too.
"The vendor keeps logs."
C2
How will we prove a rate reached the rebate engine correctly?
Why it mattersA term confirmed but keyed wrong still pays wrong.
Strong answer · warning sign
A test calculation after each publish.
A spot check at year end.
C3
What would make us stop the pilot?
Why it mattersA pre-set stop rule keeps the decision honest.
Strong answer · warning sign
A set share of wrong price terms that reach a person unmarked.
No stop rule.
23 · Questions people ask
Payer contracting questions answered: Best Price, bona fide service fees, rebate leakage and evergreen notice
In shortQuestions market access and finance teams often search, each answered on its own.
What is payer contract management in pharma?
Payer contract management is the work of keeping a drug maker's agreements with pharmacy benefit managers (PBMs), health plans, Medicare Part D sponsors, buying groups, health systems and Medicaid pools readable and acted on. It covers reading each signed document into terms, knowing which terms are in force, tracking each dated duty and checking payments against the contract. It sits between the team that negotiates and the finance systems that pay.
What is payer contracting in market access?
Payer contracting is negotiating and managing the deals in which a manufacturer pays rebates and fees in return for a place on a plan's list of covered drugs. Teams are often called managed markets or market access contracting. The US Government Accountability Office found that Medicare Part D agreements commonly tie rebates to the preferred tier, the number of competitors on it and restrictions on competitors.
What is Medicaid Best Price and how can a contract change it?
Best Price is the lowest price a manufacturer gave almost any US buyer in a quarter, net of rebates and discounts. Medicaid's basic rebate is the greater of 23.1% of the average manufacturer price or that price less Best Price. A health plan or hospital deal below today's Best Price therefore raises the rebate on every Medicaid unit, and lowers the ceiling price in the federal 340B discount program too.
Do PBM rebates count toward Best Price?
Pharmacy benefit manager (PBM) rebates, discounts and other financial transactions are excluded from Best Price, except a PBM's mail order pharmacy purchases and transactions designed to adjust prices at the retail or provider level. Rebates to a commercial health plan count, since the rule's "provider" includes a health maintenance organization and a managed care organization. Medicare Part D negotiated prices are excluded. A company's government pricing team should review each arrangement on its facts.
What is a bona fide service fee?
Under 42 CFR 447.502, a bona fide service fee is a fee at fair market value for a bona fide, itemized service actually performed for the manufacturer, which the manufacturer would otherwise perform or contract for, and which is not passed on to a client or customer. A fee meeting the test stays out of Medicaid Best Price. A fee that fails can count as a price concession, depending on who receives it.
How does the Consolidated Appropriations Act, 2026 affect PBM administrative fees?
For plan years from January 1, 2028, pharmacy benefit manager (PBM) pay tied to Medicare Part D drug use is limited to bona fide service fees, which must be flat dollar amounts at fair market value and cannot rest on a list price. Medicare's agency, CMS, proposed on October 20, 2026 to set fair market value at the cost of the service plus a reasonable markup; it is not final. Employer plans under ERISA get 100% pass-through of rebates, effectively from January 1, 2029 for calendar-year plans. Separately, proposed FTC orders would bar Express Scripts and Caremark from basing manufacturer fees on list price in their standard offerings.
What is rebate leakage, and how big is it?
Rebate leakage is money paid above what the contract requires: wrong rates, ineligible units, duplicate claims or a formulary position no longer held. MMIT, a vendor of validation services, cites its own 2021 research at 2% to 3% of revenue, about $150 million a year for a mid-sized manufacturer, and another MMIT paper says 2% to 3% of rebates. We found no independent measure, so recompute a sample of your own.
How do you calculate an evergreen contract's notice deadline?
Take the date the term ends and count back the notice days in the clause. Ninety days before January 10, 2027 is October 12, 2026. Then check whether the clause counts receipt or dispatch, how notice must be delivered, what happens on a holiday or weekend, and which amendment's notice period governs on that date. Allow days for delivery, and keep proof.
What is the difference between contract lifecycle management and payer contract management?
General contract lifecycle software stores contracts and tracks dates across a company. Payer contract management adds the pharma work: rebate tiers, service fee tests, Best Price effects, 340B exclusions and checks of rebate payments against the clause in force. Revenue management systems calculate and pay rebates, and they need someone to enter the terms correctly.
How do amendments affect which rebate rate applies?
Rebates follow the terms in force for the period they cover. A second-quarter rebate paid in October uses the second-quarter rate, even if an amendment changed it on July 1. So teams must apply each amendment in order and keep old values with their dates. Overwriting a row in a spreadsheet loses what an audit or a payment check will need.
Can AI abstract payer contracts safely?
AI can read clauses and recompute payments well enough to be useful when every value links to its clause and a person confirms price terms. It should mark what it cannot read, and it should never change a payment or send a notice on its own. Fair market value and renewal decisions stay with people. Test it on your own contracts, with planted errors, before trusting a vendor's accuracy figure.
Does FDA regulate AI used for payer contracts?
FDA's January 2025 draft guidance on AI concerns information used for regulatory decisions on a drug's safety, effectiveness or quality, and its Computer Software Assurance guidance covers device production and quality system software. Payer contracts are commercial documents outside both. The controls that matter here are the pricing record rules in 42 CFR 447.510 and, at public companies, internal control reporting.
24 · Summary
Payer contract management on one page: the method, the November 2026 rules, readiness and terms
Print this page
In shortThe whole guide on one screen: the method, the rules as of November 2026, the readiness scale and the terms.
The method
Gather every signed agreement, amendment and side letter.
Read each into terms, with a clause behind every value.
Apply amendments in order; keep old values with dates.
Turn every date-bearing clause into a duty with an owner.
Test each rate and fee for Best Price before countersignature.
Recompute every payment: rate, base, exclusions.
Decide variances inside the dispute window, and notices before the deadline. Record why.
Readiness: score 0–2 on eight questions: 0–6 explore · 7–11 pilot · 12–16 implement.
As of November 2026: Medicaid rebate cap gone since January 1, 2024 · CMS left stacking out of its September 2024 rule · Consolidated Appropriations Act, 2026 signed February 3, 2026: Part D flat fees for plan years from January 1, 2028, ERISA pass-through effectively January 1, 2029 · CMS proposed its Part D rule on October 20, 2026 · proposed FTC orders with Express Scripts and Caremark, no final order found · revised 340B pilot due January 1, 2027, with a new suit filed October 9, 2026.
14 terms
PBM
Pharmacy benefit manager: runs a plan's drug list and claims.
Formulary
A plan's list of covered drugs, in tiers.
WAC
Wholesale acquisition cost, the list price.
AMP
Average manufacturer price, reported to CMS.
Best Price
The lowest net price to almost any US buyer in a quarter.
Unit rebate
Medicaid rebate per unit: the greater of 23.1% of AMP or AMP less Best Price, plus any inflation rebate.
340B
Federal program of discounted prices for safety-net providers.
Bona fide service fee
Fair-market-value fee for a real, itemized service, kept by the entity.
Gross-to-net
The gap between list sales and what the maker keeps.
Evergreen clause
A term that renews unless someone gives notice.
Price protection
A rebate that rises when list price passes a threshold.
Terms in force
What the deal says on a date, after all amendments.
Playbook
Standard, fallback and walk-away positions by clause.
Rebate GPO
A PBM-owned group that negotiates rebates for its clients.
25 · Sources
Sources
Accessed November 2026. Regulatory status statements are as of November 2026. Federal statutes are linked through Cornell's Legal Information Institute, the CFR through govinfo. We could not open the Justice Department's Wyeth and Aventis pages, so those two were read in the reports named in their entries.
42 CFR 447.505, Determination of best price, CFR edition of October 1, 2025, the newest on govinfo on November 3, 2026. govinfo.gov
42 U.S.C. 1396r-8, Payment for covered outpatient drugs, including best price, the maximum fair price and penalties. law.cornell.edu
N. Saraceno, "Addressing Revenue Leakage", Pharmaceutical Commerce, July 7, 2023. pharmaceuticalcommerce.com
Consolidated Appropriations Act, 2026, Public Law 119-75, February 3, 2026, sections 6224 (Part D PBM accountability) and 6702 (full rebate pass through). govinfo.gov
CMS, "Medicare Program; Implementation of Sections 6219, 6220, and 6224 of the Consolidated Appropriations Act, 2026" (CMS-4214-P), proposed rule, 91 FR 66408, October 20, 2026; comments due December 15, 2026. govinfo.gov
US GAO, "Medicare Part D: CMS Should Monitor Effects of Rebates on Drug Coverage and Spending", GAO-23-107056, September 19, 2023. gao.gov
A. Fein, Drug Channels, "2025 Gross-to-Net Realities at Eight", July 21, 2026. drugchannels.net
MMIT, "Rebate Leakage: How Pharma Companies Can Prevent a Multimillion-Dollar Problem", October 13, 2022 (a vendor of rebate validation). mmitnetwork.com Another MMIT paper, its Contract Validation case study, says "2% to 3% of those rebates". mmitnetwork.com
A. Fein, Drug Channels, "The Top Pharmacy Benefit Managers of 2025", March 30, 2026. drugchannels.net
Sidley Austin, "Congress Passes Significant Federal Pharmacy Benefit Manager Reform Impacting Pharmaceutical Market Access", February 18, 2026. sidley.com
42 CFR 447.502, Definitions, including bona fide service fee, CFR edition of October 1, 2025, the newest on govinfo on November 3, 2026. govinfo.gov
CMS, Medicaid Program: Misclassification of Drugs, Program Administration and Program Integrity Updates (CMS-2434-F), 89 FR 79020, September 26, 2024. govinfo.gov
CMS, Medicare Drug Price Negotiation Program: Selected Drugs and Negotiated Prices. cms.gov
FTC, proposed Decision and Order, Express Scripts respondents, Docket 9437, section VI, February 2026. ftc.gov
FTC, "FTC Secures Major Settlement with Caremark, Resolving Antitrust Case Against Second Drug Middleman", July 14, 2026; proposed consent agreement, and OptumRx withdrawn from adjudication. ftc.gov
Baker Donelson, "HRSA Revives 340B Rebate Model Pilot Program with January 2027 Effective Date", August 13, 2026. bakerdonelson.com
J. Dresser, Frier Levitt, "340B Rebate Model Pilot Program: What Covered Entities Need to Know Before January 2027", October 15, 2026. frierlevitt.com
42 CFR 447.510, Requirements and penalties for manufacturers, CFR edition of October 1, 2025, the newest on govinfo on November 3, 2026. govinfo.gov
42 U.S.C. 256b, Limitation on prices of drugs purchased by covered entities (340B). law.cornell.edu
Goodwin, "Express Scripts Settles PBM FTC Action", February 2026. goodwinlaw.com
C. Biddle, "Stop the Bleeding", Pharmaceutical Executive, October 1, 2008 (author from a rebate software company). pharmexec.com
Frier Levitt, "Frier Levitt Reduced a PBM's Rebate Invoice to a Drug Manufacturer by 83%", October 16, 2024 (the firm's own account). frierlevitt.com
US Department of Justice, "Wyeth and Pfizer Agree to Pay $784.6 Million to Resolve Lawsuit Alleging That Wyeth Underpaid Drug Rebates to Medicaid", 2016. justice.gov Amount, date and allegation read in the New Jersey Attorney General's release of April 28, 2016. njoag.gov
US Department of Justice, "Aventis Pharmaceutical to Pay US $95.5 Million to Settle False Claims Act Allegations". justice.gov Date (May 28, 2009) and allegation read in Phillips & Cohen, June 15, 2009. phillipsandcohen.com
US Department of Justice, release on the Merck settlement of more than $650 million, February 7, 2008. justice.gov
HHS, Annual Civil Monetary Penalties Inflation Adjustment, 45 CFR 102.3, 91 FR 3665, January 28, 2026, rows for 42 U.S.C. 1396r-8(b)(3)(C). govinfo.gov. HHS notice of no adjustment for 2026, FR Doc. 2026-21524, October 21, 2026. federalregister.gov
Pharmaceutical Commerce, "Life Sciences Leaders Report Rising Gross-to-Net Complexity", February 17, 2026, on the Model N 2026 State of Revenue survey (vendor-commissioned). pharmaceuticalcommerce.com
A. Rose, EisnerAmper, on ASC 606 for life sciences companies, August 1, 2024. eisneramper.com
A. Fein, Drug Channels, "Gross-to-Net Bubble Hits $356B in 2024", July 15, 2025. drugchannels.net
A. Fein, Drug Channels, on Cigna's rebate-free pharmacy model, October 29, 2025. drugchannels.net
HCAMag, "Pharmacy benefit managers lose ground as employers press for reform", October 7, 2026. hcamag.com
FDA, "Considerations for the Use of Artificial Intelligence to Support Regulatory Decision-Making for Drug and Biological Products", draft guidance, January 2025. fda.gov
FDA, "Computer Software Assurance for Production and Quality Management System Software", guidance, February 3, 2026. fda.gov
European Commission, consultation on EudraLex Volume 4, Chapter 4, Annex 11 and new Annex 22, July 7 to October 7, 2025. health.ec.europa.eu Draft Annex 22 text: picscheme.org
European Commission, EudraLex Volume 4, EU GMP guidelines: annex list, showing Annex 11 (revision January 2011) and no Annex 22, read November 3, 2026. health.ec.europa.eu
Next step
See it on your own payer contracts.
Explore the solution, or bring a sample of your own agreements, amendments and recent payments, and we will read them with you, every term linked to its clause.
We use essential cookies to make this site work, and cookieless, anonymised analytics to understand how it's used. "Accept all" also turns on Google Analytics, which sets cookies. Privacy policy